Pharmaceutical Water System Monitoring: Conductivity & TOC Compliance in Singapore

Why Pharmaceutical Water Quality Is Uniquely Demanding

Water is the single most widely used raw material in pharmaceutical manufacturing. It appears in drug formulations, cleaning processes, steam sterilisation, and equipment rinsing. Unlike most raw materials, water is not tested in a discrete batch and released; it must meet specification continuously, in real time, at every point of use in a circulating distribution loop.

This creates a compliance challenge that is fundamentally different from typical raw material control. You cannot hold a shipment of water while waiting for laboratory results. Instead, the facility must demonstrate through a validated system design, continuous online monitoring, and calibrated instrumentation that water leaving every point of use is safe to use in manufacture, every hour of every day.

Conductivity and Total Organic Carbon (TOC) are the two primary in-process attributes monitored online precisely because they are fast, continuous, and non-destructive. Conductivity detects ionic contamination (inorganic salts, dissolved minerals) while TOC detects organic contamination from microbial metabolites, cleaning agent residues, and system leachables. Together, they provide a real-time window into water quality that point-in-time microbiological tests alone cannot.

Singapore's Regulatory Framework for Pharmaceutical Water

In Singapore, pharmaceutical manufacturing sites holding a Manufacturer's Licence from the Health Sciences Authority (HSA) must comply with the HSA Good Manufacturing Practice guidelines. These guidelines are written to be consistent with the PIC/S Guide to Good Manufacturing Practice for Medicinal Products (PE 009), which is the international harmonised GMP standard accepted across Singapore's major export markets including the EU, Australia, and the United States.

PIC/S PE 009 Annex 1 (sterile manufacturing) and the main guide chapter on production specify that water of appropriate quality must be used in manufacturing, that systems must be validated, and that all instruments used in quality-critical measurements must be calibrated and their performance maintained. These requirements flow directly into HSA's audit expectations for Singapore sites.

Which Pharmacopoeial Standard Applies?

Singapore does not publish its own water quality pharmacopoeia. Instead, HSA auditors accept compliance with the major recognised pharmacopoeias: the United States Pharmacopeia (USP), the European Pharmacopoeia (EP), and the Japanese Pharmacopoeia (JP). Most Singapore pharmaceutical manufacturers use USP as their reference standard, which means USP <645> (Water Conductivity) and USP <643> (Total Organic Carbon) are the primary test methods applied.

Note that while PUB (Singapore's Public Utilities Board) regulates potable water quality at the point of supply to the building, potable water used as feed to pharmaceutical purification systems is not itself a pharmaceutical grade. Its treatment into Purified Water or WFI is the site's responsibility under HSA GMP.

Understanding USP Conductivity Testing: Stage 1, 2, and 3

USP <645> defines a three-stage conductivity test. Most pharmaceutical facilities operating online monitoring systems use Stage 1, which is the simplest and most practical for continuous online measurement. It is important that your compliance team understands which stage your water system qualification protocol commits to, because the calibration and instrument requirements differ between online and offline measurement.

Stage 1, in-Process Online Measurement

Stage 1 sets a single temperature-specific limit based on the measured temperature at the time of the conductivity reading. At 25°C, the limit is 1.3 µS/cm. This is the stage used by online conductivity transmitters installed directly in the water distribution loop. The transmitter must have a calibrated temperature sensor integrated into the probe assembly, because temperature compensation to the reference temperature is mandatory. Raw conductivity readings without temperature correction are not compliant.

Stage 2 and 3. Laboratory Verification

Stages 2 and 3 are applied in laboratory settings when Stage 1 is inconclusive or when the system is being qualified. Stage 2 involves measuring conductivity after pH adjustment (to remove CO₂ equilibrium effects); Stage 3 is a laboratory reference measurement with strict sample handling requirements. These stages require calibrated laboratory benchtop conductivity meters rather than online transmitters. Understanding the distinction matters for your calibration scope. You need both your online sensors and your laboratory reference instruments to have current calibration certificates.

TOC Monitoring: Instrument Qualification and Calibration Requirements

Total Organic Carbon analysers used for pharmaceutical water testing must satisfy both USP <643> system suitability requirements and the facility's instrument qualification and calibration programme. These are two separate but related obligations that are frequently confused during audits.

USP System Suitability vs. Calibration

System suitability (as described in USP <643>) is an operational check the operator performs before each analytical run using two reference solutions: a sucrose standard (to test the analyser's oxidation efficiency) and a 1,4-benzoquinone standard (to test system response to hard-to-oxidise compounds). Both must achieve a response factor within USP-specified limits before the instrument can be used for compliance measurements. This check is the operator's daily assurance that the analyser is working correctly.

Calibration, however, is a separate metrological activity that establishes the relationship between the instrument's output signal and known TOC concentrations traceable to a national measurement standard. Calibration is performed by an accredited laboratory at defined intervals (typically every 6 to 12 months for pharmaceutical applications), and produces a calibration certificate with stated measurement uncertainty. System suitability does not replace calibration; both are required.

Instruments Requiring Calibration in a Pharmaceutical Water System

A typical pharmaceutical water system. Comprising a purification skid (reverse osmosis, electrodeionisation, or distillation) and a recirculating distribution loop. Contains a range of instruments that must be included in the site's calibration programme. Facilities managers often focus only on the primary quality attributes (conductivity and TOC), overlooking the supporting sensors whose failure would compromise the entire monitoring system.

Understanding which instruments require accredited calibration versus in-house verification is a foundational decision in your calibration programme. For more on building a defensible calibration programme, see our guide on ISO/IEC 17025 calibration requirements, which explains the traceability chain that makes your certificates audit-proof.

Step-by-Step Compliance Process for Singapore Pharmaceutical Facilities

Achieving and maintaining compliance with HSA GMP water system requirements follows a structured lifecycle. New facilities must complete the full qualification cycle before releasing any water for pharmaceutical use; established facilities must maintain ongoing compliance through continuous monitoring and periodic requalification activities.

Step 1. Design Qualification (DQ)

Before installing the water system, document that the design meets the intended purpose. This includes selecting appropriate materials (e.g. 316L stainless steel or PVDF for distribution piping), specifying loop velocity to prevent biofilm formation (>1 m/s is the common criterion), and confirming that instrument specifications match the measurement requirements. Your DQ should identify every instrument that will require calibration as part of the validated system.

Step 2. Installation Qualification (IQ)

Verify that the installed system matches the approved design. IQ for water systems includes confirming that all instruments are of the specified make and model, that calibration tags are in place with current calibration due dates, and that calibration certificates are on file before the system is used for any pharmaceutical purpose. Auditors frequently check that IQ documentation includes the calibration status of each instrument at installation.

Step 3. Operational Qualification (OQ)

Demonstrate that the system operates within defined parameters across its operating range. For water quality monitoring, OQ testing includes challenging the system at minimum and maximum design flow rates, confirming that conductivity and TOC readings are within specification across the challenge conditions, and verifying that all alarms and interlocks function correctly. All instruments used during OQ testing must have current calibration certificates, and a calibration certificate must be filed for each instrument with the OQ report.

Step 4. Performance Qualification (PQ)

Demonstrate that the system consistently produces water of the required quality under actual production conditions. USP guidance suggests a three-phase PQ approach over approximately one year, covering seasonal variation and full operational variability. PQ is the evidence base that allows the site to release the water system for routine production use. Ongoing monitoring data collected during PQ must come from calibrated instruments. Any out-of-calibration period during PQ invalidates the data collected in that window.

Step 5. Routine Monitoring and Calibration Maintenance

After system release, the facility must maintain the validated state through continuous monitoring, periodic re-calibration of all instruments, trend analysis of quality data, and periodic requalification when changes are made to the system. Your calibration programme must track due dates for every instrument, initiate re-calibration before expiry, and manage any periods where instruments are found to be out of tolerance. Including a retrospective impact assessment on data collected since the last in-tolerance calibration.

Penalties for Non-Compliance in Singapore

HSA's enforcement approach for GMP non-compliance is risk-based. Minor deficiencies (e.g. a slightly overdue calibration that is still within tolerance) result in observations that must be addressed in a CAPA plan submitted to HSA. Major deficiencies. Including uncalibrated critical instruments, missing calibration records, or systemic failures in the water monitoring programme. Trigger mandatory CAPA with defined closure dates and may result in follow-up inspection.

Critical deficiencies, which include situations where uncalibrated instruments were used to release batches that have already been distributed, can result in product recall, GMP certificate suspension, and requirements for third-party auditing at the facility's expense before the certificate is reinstated. For export-oriented manufacturers, an HSA GMP suspension also triggers notifications to regulators in importing countries, which can disrupt export registrations and supply agreements.

Beyond HSA's direct enforcement, pharmaceutical manufacturers selling into the EU, Australia, or the US must maintain GMP compliance acceptable to those authorities. European QP (Qualified Person) certification and FDA import alert listing are additional commercial consequences that can flow from water system non-compliance identified during HSA audits.

Calibration Traceability: What Auditors Look For

A calibration certificate is only as good as the traceability chain behind it. HSA auditors and international GMP inspectors will look beyond the certificate itself to confirm that the calibration laboratory issuing the certificate holds recognised accreditation. Either SAC-SINGLAS (Singapore), UKAS (UK), A2LA (US), NATA (Australia), or another ILAC MRA signatory body. Certificates from non-accredited laboratories, or from the equipment manufacturer's service department without independent accreditation, are frequently challenged as inadequate for GMP purposes.

The certificate must state the measurement uncertainty of each calibration point, the reference standard used, and the traceability chain back to a national or international measurement standard. For conductivity, this means traceability to a certified KCl reference standard with a stated concentration uncertainty; for TOC, traceability to NIST Standard Reference Material 1994 (sucrose) or equivalent certified reference material.

For a deeper explanation of what makes a calibration certificate defensible under audit, see our article on accredited vs non-accredited calibration, which explains the specific differences auditors look for and why accreditation status matters in a regulated industry.